NiKang Therapeutics

Ukraine
Karavelove, Mykolaiv, Ukraine

Company profile

NiKang Therapeutics company profile

NiKang Therapeutics is an early-stage biotech company focused on discovering and developing innovative small molecule oncology medicines to help patients with unmet medical needs. Its discovery approach is informed by target structure biology and capitalizes on structure-based drug design enabling a rapid and efficient discovery and development of proprietary drug candidates with the most desirable pharmacological features into clinical studies.

Business identity

Contact email
[email protected]
Phone number
302 644 5450
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2017-01-01, Year

Headquarters

Country code
UA
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
3
Total equity funding
$260M
Last funding
Series C / $200M / 2021-05-26
Last equity funding
Series C / $200M
Investors
24
Lead investors
5
Founders
2
Articles
80

Founders and investors

Founders

Yan LouZhenhai Gao

Lead investors

CBC GroupCormorant Asset ManagementHBM Healthcare InvestmentsOctagon Capital AdvisorsRTW Investments

Investors

BlackRockCormorant Asset ManagementJanus Henderson InvestorsRA Capital ManagementWellington Management